Professor of Surgery and Chief of the Division of Thoracic and Cardiovascular Surgery, University of Louisville
| Role | Organisation | Sources |
|---|---|---|
| Director of the Heart Transplant and Mechanical Assist Device Program (former) | Jewish Hospital | GBS Ventures (30 Aug 2010), GBS Ventures (10 Aug 2009), GBS Ventures (24 Nov 2008) |
| Professor of Surgery and Chief of the Division of Thoracic and Cardiovascular Surgery (former) | University of Louisville | GBS Ventures (15 Jun 2010), GBS Ventures (10 Aug 2009) |
Stories naming Dr Mark Slaughter. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Sunshine Heart's chief executive reports to shareholders on the C-Pulse trial: halfway through its US feasibility study, first two minimally invasive implants completed and new hospitals in Australia, Canada and the US joining.
A reposted ASX announcement from Sunshine Heart reports the first minimally invasive implant of its C-Pulse heart assist system, carried out in early June by a Louisville surgeon under a US FDA feasibility trial.
Sunshine Heart announces that two female patients at Louisville's Jewish Hospital are the first US women implanted with its C-Pulse heart assist system in an FDA-approved 20-patient feasibility trial.
Sunshine Heart says a Kentucky hospital is the first US site cleared by an ethics board to join its FDA-approved C-Pulse heart failure trial, with patient enrolment expected once contracts are signed.